ImmuCell (ICCC) announced that it is initiating Investigational Product use of Re-Tain. The company intends to use this opportunity to test market acceptance of the product through a controlled launch. This initiative also helps the company utilize available inventory before shelf-life expiration. This opportunity is not expected to generate significant revenue or profit.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICCC: